• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Generic Entresto means Vegas will debut restructured CV team?

Quote

anonymous

Guest
News like we just received has an effect on the stock price, therefore the company will have to show Wall Street and its shareholders that they are being proactive. It also makes good pharmaceutical business sense. This is not new. Restructure and move forward with a new CV team come Vegas, a team where each salesperson will be focused on Leqvio with Entresto as a secondary product. I could be wrong, perhaps they ride out this generic threat for another year?
 




anonymous said:
News like we just received has an effect on the stock price, therefore the company will have to show Wall Street and its shareholders that they are being proactive. It also makes good pharmaceutical business sense. This is not new. Restructure and move forward with a new CV team come Vegas, a team where each salesperson will be focused on Leqvio with Entresto as a secondary product. I could be wrong, perhaps they ride out this generic threat for another year?
Click to expand...
Half of us will be gone before Vegas
 












anonymous said:
News like we just received has an effect on the stock price, therefore the company will have to show Wall Street and its shareholders that they are being proactive. It also makes good pharmaceutical business sense. This is not new. Restructure and move forward with a new CV team come Vegas, a team where each salesperson will be focused on Leqvio with Entresto as a secondary product. I could be wrong, perhaps they ride out this generic threat for another year?
Click to expand...

Unfortunately Novartis will not do the right thing and keep us together until Pelacarsen launch. Leqvio and disease state awareness doesn't warrant 850 reps. I think all the CV2 reps will be gone before Vegas meeting. They can save hundreds of millions by cutting the CV salesforce in half and this will look good on Wallstreet. Probably make CV1 go back to 70/30. Novartis will ride the Entresto gravy train all the way until the generics hits the market.
 




anonymous said:
Unfortunately Novartis will not do the right thing and keep us together until Pelacarsen launch. Leqvio and disease state awareness doesn't warrant 850 reps. I think all the CV2 reps will be gone before Vegas meeting. They can save hundreds of millions by cutting the CV salesforce in half and this will look good on Wallstreet. Probably make CV1 go back to 70/30. Novartis will ride the Entresto gravy train all the way until the generics hits the market.
Click to expand...


They won’t just eliminate CV2 dumbass. It’s always a mix when it comes to sales. Yes some cv2 will be cut, but they’ll also eliminate some cv1 & ISS jobs depending on the region and area. They look at tenure w/ Novartis, performance, PIPs & address proximity to territory.
 




anonymous said:
Unfortunately Novartis will not do the right thing and keep us together until Pelacarsen launch. Leqvio and disease state awareness doesn't warrant 850 reps. I think all the CV2 reps will be gone before Vegas meeting. They can save hundreds of millions by cutting the CV salesforce in half and this will look good on Wallstreet. Probably make CV1 go back to 70/30. Novartis will ride the Entresto gravy train all the way until the generics hits the market.
Click to expand...

They will not do a simple CV2 cut, geography plays a big part in how they handle restructures. It will be a mixed bag of layoffs. I don’t see a long enough Entresto bridge to the Pelacarsen launch, makes too much sense to cut before Vegas meeting. They open up the meeting with the usual speech about how hard these things are to do, then quickly transition to pumping everyone up on everything that they have moving forward. It’s business, it makes sense and most people will be happy to have survived.
 




anonymous said:
They won’t just eliminate CV2 dumbass. It’s always a mix when it comes to sales. Yes some cv2 will be cut, but they’ll also eliminate some cv1 & ISS jobs depending on the region and area. They look at tenure w/ Novartis, performance, PIPs & address proximity to territory.
Click to expand...

Seems like this post offended some CV2 reps. No need to get nasty. Let me know how things turn out for you when the cuts come.
 












anonymous said:
Seems like this post offended some CV2 reps. No need to get nasty. Let me know how things turn out for you when the cuts come.
Click to expand...
You were probably one of the ones who thought all the PCP reps would be cut in the last reorg too. In my area, more were retained than cv. Tenure had nothing to do with it either. Some Novartis lifers were let go, some kept. Geography didn’t seem to play a huge part. Numbers didn’t seem to play any part. I know someone who won President’s Club and got let go. It just won’t be as simple as you think.
 
























It is a much better career choice to sell cars vs. pharmaceuticals. The government wants everyone to get new cars anyway that produce lower carbon dioxide. The market is enormous and growing. Cars salespeople need no college degree, work in air conditioned dealerships and customers call them when lease is up for renewal. No cold calling. Pharmaceutical sales representatives beat the pavement door to door in August heat bringing lunch and snacks to 30 office staff. The doctors barely say hello, much less prescribe your product. Doctors slam door in your face. There are European car sales people in large metro areas making 300k a year where pharmaceutical representatives receive no stock options, 3% raise, then fired. Car sales people build relationships overtime with their customers and customers renew leases with brand loyalty. Pharmaceuticals can build relationships over years that become completely useless with territory change or disease change. For example, will your years building relationships in Cardiology help you selling your newly assigned oncology medicine? Pharma rep is fired with no acquired skills where car sales people can work into their 70s ,part time, selling cars for extra spending money. Get out of pharmaceuticals while you can!!! It is only going to get worse.
 




anonymous said:
It is a much better career choice to sell cars vs. pharmaceuticals. The government wants everyone to get new cars anyway that produce lower carbon dioxide. The market is enormous and growing. Cars salespeople need no college degree, work in air conditioned dealerships and customers call them when lease is up for renewal. No cold calling. Pharmaceutical sales representatives beat the pavement door to door in August heat bringing lunch and snacks to 30 office staff. The doctors barely say hello, much less prescribe your product. Doctors slam door in your face. There are European car sales people in large metro areas making 300k a year where pharmaceutical representatives receive no stock options, 3% raise, then fired. Car sales people build relationships overtime with their customers and customers renew leases with brand loyalty. Pharmaceuticals can build relationships over years that become completely useless with territory change or disease change. For example, will your years building relationships in Cardiology help you selling your newly assigned oncology medicine? Pharma rep is fired with no acquired skills where car sales people can work into their 70s ,part time, selling cars for extra spending money. Get out of pharmaceuticals while you can!!! It is only going to get worse.
Click to expand...

Also, government is tired of paying 5 times the price for branded pharmaceuticals than Japan, France, Canada and the UK. Government wants everyone to get modern low emissions cars.
 




anonymous said:
It is a much better career choice to sell cars vs. pharmaceuticals. The government wants everyone to get new cars anyway that produce lower carbon dioxide. The market is enormous and growing. Cars salespeople need no college degree, work in air conditioned dealerships and customers call them when lease is up for renewal. No cold calling. Pharmaceutical sales representatives beat the pavement door to door in August heat bringing lunch and snacks to 30 office staff. The doctors barely say hello, much less prescribe your product. Doctors slam door in your face. There are European car sales people in large metro areas making 300k a year where pharmaceutical representatives receive no stock options, 3% raise, then fired. Car sales people build relationships overtime with their customers and customers renew leases with brand loyalty. Pharmaceuticals can build relationships over years that become completely useless with territory change or disease change. For example, will your years building relationships in Cardiology help you selling your newly assigned oncology medicine? Pharma rep is fired with no acquired skills where car sales people can work into their 70s ,part time, selling cars for extra spending money. Get out of pharmaceuticals while you can!!! It is only going to get worse.
Click to expand...
I know car salespeople don’t make anywhere near what I make where I live. Our dealerships churn through young pups pretty fast.
 




anonymous said:
It is a much better career choice to sell cars vs. pharmaceuticals. The government wants everyone to get new cars anyway that produce lower carbon dioxide. The market is enormous and growing. Cars salespeople need no college degree, work in air conditioned dealerships and customers call them when lease is up for renewal. No cold calling. Pharmaceutical sales representatives beat the pavement door to door in August heat bringing lunch and snacks to 30 office staff. The doctors barely say hello, much less prescribe your product. Doctors slam door in your face. There are European car sales people in large metro areas making 300k a year where pharmaceutical representatives receive no stock options, 3% raise, then fired. Car sales people build relationships overtime with their customers and customers renew leases with brand loyalty. Pharmaceuticals can build relationships over years that become completely useless with territory change or disease change. For example, will your years building relationships in Cardiology help you selling your newly assigned oncology medicine? Pharma rep is fired with no acquired skills where car sales people can work into their 70s ,part time, selling cars for extra spending money. Get out of pharmaceuticals while you can!!! It is only going to get worse.
Click to expand...
If selling cars is so good, why don't you head off to Europe? Such an idiot.
 




Top Bottom
Back
Quote